The autoimmune process in Hashimoto's disease is distinct from the mechanisms affected by GLP-1 therapy, and no causal relationship has been established in clinical studies or post-marketing surveillance
Furthermore, its tolerability profile, which includes weight gain, edema/fluid retention, fractures, and (rarely) bladder cancer in long-term use, could hinder its potential repositioning for depression [173]
Coverage varies widely, so review the current terms and any documentation requirements directly on Mochi Health's site before enrolling
A Cross-Sectional Survey of University Students
For the outcome of cardiovascular death, SGLT2i use reduced the outcome by 20% vs 12% for finerenone, and for HHF there was a reduction of 43% for SGLT2i vs 22% for finerenone
Foods, 12 (21), 4018